{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:09:15Z","timestamp":1791925755962,"version":"4.3.4"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,8,15]]},"DOI":"10.2169\/internalmedicine.2596-18","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:33:46Z","timestamp":1558478026000},"page":"2367-2372","source":"Crossref","is-referenced-by-count":20,"title":["Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"58","author":[{"given":"Keisuke","family":"Matsuo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Saitama Cardiovascular and Respiratory Center, Japan"},{"name":"Department of Cardiology, Saitama Medical University International Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishiguro","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatomo","family":"Najama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saitama Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saitama Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saitama Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Mutou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saitama Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.lungcan.2016.06.025","volume":"99","author":"H Semper","year":"2016","unstructured":"1. Semper H, Muehlberg F, Schulz-Menger J, Allewelt M, Grohe C. Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung. Lung Cancer 99: 117-119, 2016.","journal-title":"Lung Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tay RY, Blackley E, McLean C, et al. Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy. Br J Cancer 117: 921-924, 2017.","DOI":"10.1038\/bjc.2017.253"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gibson R, Delaune J, Szady A, Markham M. Suspected autoimmune myocarditis and cardiac conduction abnormalities with nivolumab therapy for non-small cell lung cancer. BMJ Case Rep 2016: 2016.","DOI":"10.1136\/bcr-2016-216228"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tadokoro T, Keshino E, Makiyama A, et al. Acute lymphocytic myocarditis with anti-PD-1 antibody nivolumab. Circ Heart Fail 9: 2016.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003514"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tajmir-Riahi A, Bergmann T, Schmid M, Agaimy A, Schuler G, Heinzerling L. Life-threatening autoimmune cardiomyopathy reproducibly induced in a patient by checkpoint inhibitor therapy. J Immunother 41: 35-38, 2018.","DOI":"10.1097\/CJI.0000000000000190"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Norwood TG, Westbrook BC, Johnson DB, et al. Smoldering myocarditis following immune checkpoint blockade. J Immunother Cancer 5: 91, 2017.","DOI":"10.1186\/s40425-017-0296-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tawbi HA, Forsyth PA, Algazi A, et al. Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med 379: 722-730, 2018.","DOI":"10.1056\/NEJMoa1805453"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Johnson DB, Balko JM, Compton ML, et al. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 375: 1749-1755, 2016.","DOI":"10.1056\/NEJMoa1609214"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kimura T, Fukushima S, Miyashita A, et al. Myasthenic crisis and polymyositis induced by one dose of nivolumab. Cancer Sci 107: 1055-1058, 2016.","DOI":"10.1111\/cas.12961"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Heinzerling L, Ott PA, Hodi FS, et al. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy. J Immunother Cancer 4: 50, 2016.","DOI":"10.1186\/s40425-016-0152-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Matson DR, Accola MA, Rehrauer WM, Corliss RF. Fatal myocarditis following treatment with the PD-1 inhibitor nivolumab. J Forensic Sci 63: 954-957, 2018.","DOI":"10.1111\/1556-4029.13633"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fukasawa Y, Sasaki K, Natsume M, et al. Nivolumab-induced myocarditis concomitant with myasthenia gravis. Case Rep Oncol 10: 809-812, 2017.","DOI":"10.1159\/000479958"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest 151: 193-203, 2017.","DOI":"10.1016\/j.chest.2016.10.010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wolchok JD. PD-1 Blockers. Cell 162: 937, 2015.","DOI":"10.1016\/j.cell.2015.07.045"},{"key":"15","unstructured":"15. KEYTRUDA<sup>\u00ae<\/sup> Interview Form ver9 [Internet]. [cited 2019 Jan. 29]. Available from: http:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/GeneralList\/4291435A1 (in Japanese)"},{"key":"16","unstructured":"16. Chugai Pharmaceutical. TECENTRIQ<sup>\u00ae<\/sup> Intravenous Infusion 1200 mg - Unresectable, advanced or recurrent non-small cell lung cancer - Report of adverse drug reactions collected in early post-marketing phase vigilance, 2019 January."},{"key":"17","doi-asserted-by":"crossref","first-page":"e000247","DOI":"10.1136\/esmoopen-2017-000247","volume":"2","author":"G Varricchi","year":"2017","unstructured":"17. Varricchi G, Galdiero MR, Marone G, et al. Cardiotoxicity of immune checkpoint inhibitors. ESMO Open 2: e000247, 2017.","journal-title":"ESMO Open","ISSN":"https:\/\/id.crossref.org\/issn\/2059-7029","issn-type":"print"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109: 1250-1258, 2004.","DOI":"10.1161\/01.CIR.0000118493.13323.81"},{"key":"19","unstructured":"19. Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 36: 1714-1768, 2018."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/16\/58_2596-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T10:46:30Z","timestamp":1663497990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/16\/58_2596-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":19,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2596-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,15]]}}}